Wednesday, January 27, 2021
wellness India Expo
Home Tags Chemotherapy

Tag: Chemotherapy

Breast cancer treatment takes a big leap forward

A new study by the cancer research group at the Department of Biotechnology's Institute of Life Sciences (DBT-ILS) has resolved the mystery and promises to pave the way for developing better drugs for breast cancer................

Study opens new avenue for preventing cancer

The scientists based at the National Institute of Immunology have found a way to stop the degradation of a protein called p53 that prevents cancer cells from proliferating and forming tumours in the body...................

India-UK project to find affordable solutions to cancer

In order to promote research in affordable approaches to cancer, the government’s Department of Biotechnology has joined hands with British charity, Cancer Research UK, to launch a research challenge for affordable approaches to cancer................

Immunotherapy may offer ray of hope for triple negative breast cancer...

Besides boosting the immune system of the body, Immunotherapy has shown a great deal of promise in treating certain cancers and is now being recognized as a potential therapeutic approach in Triple Negative Breast Cancer too...………..

Mathematics helps scientists to make cancer treatment more effective

Researchers tested two treatment protocols based on various interactions: one using only radiation and medication while the second included immunotherapy...………….

Breast cancer patients likely to benefit under a new precision medicine...

The TAILORx study, the largest ever breast cancer treatment trial published in the New England Journal of Medicine in June, has concluded that about 70 percent of early-stage breast cancer patients could avoid agony of chemotherapy by...…………………..

Women with breast cancer may be spared chemotherapy, but…..

Researchers have identified patients who will best benefit from chemotherapy based on the Oncotype Dx test, writes Dr Radhika Nair............

US FDA approves Mylan & Biocon’s biosimilar, Fulphila

Second FDA-approved biosimilar through the Mylan-Biocon collaboration,, Fulphila is expected to be the first biosimilar pegfilgrastim available in the U.S. to help patients with nonmyeloid cancers reduce the risk of infection...............

Microneedle-based system can take pain away from vaccinations

Microneedle patch technology could offer economic and manufacturing advantages besides reducing the cost of vaccination since self-administration can eliminate the need of health workers for vaccination..................

New strategy proposed to make breast cancer therapy effective

The scientists have identified mechanisms that could form the basis to develop combination therapy along with conventional drugs to tackle aggressive triple negative breast cancer.............